Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.
Catheter Cardiovasc Interv
; 91(3): 387-395, 2018 02 15.
Article
en En
| MEDLINE
| ID: mdl-28471086
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de la Arteria Coronaria
/
Fármacos Cardiovasculares
/
Angioplastia Coronaria con Balón
/
Implantes Absorbibles
/
Diabetes Mellitus
/
Stents Liberadores de Fármacos
/
Everolimus
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2018
Tipo del documento:
Article